...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo(3.2.2)nonane thiosemicarbazones derived from acyl diazines.
【24h】

Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo(3.2.2)nonane thiosemicarbazones derived from acyl diazines.

机译:衍生自酰基二嗪的(4)N-氮杂双环(3.2.2)壬烷硫代半碳杂唑酮的铜(II)和铁(II)配合物的合成,细胞毒性和抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of thiosemicarbazones (TSCs) (bearing a (4)N-azabicyclo[3.2.2]nonane moiety) derived from 3-acylpyridazines, 4-acetylpyrimidines, and 2-acetylpyrazines (1-8) were synthesized as potential antitumor agents. TSCs 1-8 exhibited potent cytotoxic activity against human acute lymphoblastic leukemia CCRF-CEM cells (IC(50) = 0.05-0.77 &mgr;M) and colon adenocarcinoma HT-29 cells (IC(50) = 0.011-2.22 microM). Copper II complexes of TSCs 1-8 showed significant improvement in cytotoxic activity against HT-29 cells (IC(50) = 0.004-1.51 microM) by a factor of 3. However, complexation of ligands 1, 2, 4, and 6 with Fe(II) results in lowering of cytotoxic activity by a factor of approximately 7. In clonogenic assays involving human tumor cells of different tumor origins, compounds 5, 7, 8, and their copper complexes 5Cu(II), 7Cu(II), and 8Cu(II) exhibited remarkable cytotoxic activities with mean IC(50) values of 6, 0.18, 1, 1, 0.37, and 0.37 nM, respectively. In particular, the compounds were highly effective against human colon carcinoma and large and small cell lung carcinoma cells. The TSC derivative 5 was evaluated in vivo in nude mice bearing LXFL 529 human large cell lung carcinoma cells. With respect to antitumor activity, application of 30 mg/kg/d resulted in moderate inhibition (42%) of tumor growth. No effect on tumor growth was observed at a dose of 10 mg/kg/d. However, a dose of 40 or 60 mg/kg/d resulted in 50 and 75% death, respectively, in the treated mice, indicating the high toxicity of these compounds. Using human liver microsomes, compound 5 was found to be rapidly and highly metabolized in vitro. In actual fact, only 2% of the unmetabolized compound could be detected in the incubation medium after 5 min. The IC(50) for cell proliferation (0.006-0.022 microM) elicited by these compounds is much lower than that of the inhibition of [(14)C]cytidine incorporation into DNA (0.18-3.32 microM). These compounds are also noncell cycle specific agents. Interestingly, compounds 5, 5Cu(II), and 8 were found to be potent inducers of apoptosis in Burkitt's lymphoma cells.
机译:合成了一系列衍生自3-酰基哒嗪,4-乙酰基嘧啶和2-乙酰基吡嗪(1-8)的硫代半脲(TSC)(带有(4)N-氮杂双环[3.2.2]壬烷部分)。 TSC 1-8对人急性淋巴细胞白血病CCRF-CEM细胞(IC(50)= 0.05-0.77μM)和结肠腺癌HT-29细胞(IC(50)= 0.011-2.22 microM)表现出有效的细胞毒活性。 TSC 1-8的铜II配​​合物对HT-29细胞的细胞毒性活性显着提高(IC(50)= 0.004-1.51 microM),提高了3倍。但是,配体1、2、4和6与Fe(II)导致细胞毒性活性降低约7倍。在涉及不同肿瘤起源的人类肿瘤细胞,化合物5、7、8及其铜络合物5Cu(II),7Cu(II)的克隆形成测定中,和8Cu(II)表现出显着的细胞毒性活性,平均IC(50)值为6、0.18、1、1、0.37和0.37 nM。特别地,所述化合物对人结肠癌以及大细胞和小细胞肺癌细胞高度有效。在具有LXFL 529人大细胞肺癌细胞的裸鼠体内评估了TSC衍生物5。在抗肿瘤活性方面,以30 mg / kg / d的剂量施用可适度抑制(42%)肿瘤生长。剂量为10 mg / kg / d时未观察到对肿瘤生长的影响。然而,40或60 mg / kg / d的剂量在治疗的小鼠中分别导致50和75%的死亡,表明这些化合物的高毒性。使用人肝微粒体,发现化合物5在体外迅速且高度代谢。实际上,在5分钟后的温育培养基中只能检测到2%的未代谢化合物。这些化合物引起的细胞增殖的IC(50)(0.006-0.022 microM)远低于抑制[(14)C]胞苷掺入DNA的IC(50)(0.18-3.32 microM)。这些化合物也是非细胞周期特异性试剂。有趣的是,发现化合物5、5Cu(II)和8是Burkitt淋巴瘤细胞的有效凋亡诱导剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号